project id: TCGA-ACC; case submitter id: TCGA-OR-A5KT; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.61; rna integrity number: 8.9; age at index: 44; days to birth: -16217; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 16217; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2895.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2399; initial weight: 80.0; sample id: 92522f10-7730-4b1c-8916-428e86da1d4f; sample submitter id: TCGA-OR-A5KT-01A; portion id: edd344b8-dd3f-4f61-8f42-0f8827f7e7fa; portion submitter id: TCGA-OR-A5KT-01A-11; slide id: 5a16c07d-29f3-405c-b7ca-d7c85340bfc2; slide submitter id: TCGA-OR-A5KT-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 100.0; section location: TOP;